What is Rhythm Pharmaceuticals, Inc.'s capex?

Rhythm Pharmaceuticals, Inc. (RYTM) reported capex of $238.25K in Q4 2025.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s capex?

Over 3 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s capex has grown at a 30.0% compound annual growth rate (CAGR), from $434K to $953K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Rhythm Pharmaceuticals, Inc. RYTM CapEx

Discontinued — last reported Q4 '25

CapEx at other companies

Eli LillyLLY

$2.33B+54.0%

Arrowhead ResearchARWR

$2.57M-51.6%

AlkermesALKS

$4.09M-59.5%

Praxis Precision Medicines, Inc.PRAX

$62K—

BridgeBio PharmaBBIO

$69K—

Mirum Pharmaceuticals, Inc.MIRM

——

Other financials

Income statement

See full

Revenue$60.1M+83.8%

Gross profit$53.0M+82.3%

Operating income-$52.4M-11.4%

Net income-$55.6M-12.4%

EPS (diluted)-$0.83-2.5%

Balance sheet

See full

Cash & equivalents$62.1M-41.4%

Total debt$112.3M-1.1%

Total equity$122.9M+549%

Total assets$442.3M+14.4%

Cash flow

See full

Operating cash flow-$44.2M-9.5%

Free cash flow-$29.2M-2.4%

Valuation

See full

Market cap$6.64B+77.3%

Enterprise value$6.69B+78.4%

P/S30.6×+3.2×

Profitability

See full

Gross margin89.4%-0.2pp

Operating margin-90.9%-19.8pp

Net margin-93.3%-18.2pp

FCF margin-61.5%-14.1pp

Returns & leverage

See full

Return on equity-285.8%-68.9pp

Debt / equity0.9×-5.1×

Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s capex?: Rhythm Pharmaceuticals, Inc. (RYTM) reported capex of $238.25K in Q4 2025.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s capex?: Over 3 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s capex has grown at a 30.0% compound annual growth rate (CAGR), from $434K to $953K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.